---
title: "MIRM: Robust sales growth and a rich late-stage pipeline position the company for five potential approvals by 2027"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291467602.md"
description: "Net product sales are projected to reach $660–680M in 2026, driven by strong growth in rare liver and genetic disease medicines. Multiple late-stage pipeline assets, including LIVMARLI, Volixibat, Brelovitug, and Zilurgisertib, are advancing toward regulatory milestones, with five potential approvals or label expansions expected by 2027.Original document: Mirum Pharmaceuticals, Inc. [MIRM] Slides Release — Jul. 1 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-01T22:24:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291467602.md)
  - [en](https://longbridge.com/en/news/291467602.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291467602.md)
generator: "portal-rs"
---

# MIRM: Robust sales growth and a rich late-stage pipeline position the company for five potential approvals by 2027

Net product sales are projected to reach $660–680M in 2026, driven by strong growth in rare liver and genetic disease medicines. Multiple late-stage pipeline assets, including LIVMARLI, Volixibat, Brelovitug, and Zilurgisertib, are advancing toward regulatory milestones, with five potential approvals or label expansions expected by 2027.

Original document: Mirum Pharmaceuticals, Inc. \[MIRM\] Slides Release — Jul. 1 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [MIRM.US](https://longbridge.com/en/quote/MIRM.US.md)

## Related News & Research

- [Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | MIRM Stock News](https://longbridge.com/en/news/298957714.md)
- [20 rare state quarters that are worth more than face value](https://longbridge.com/en/news/298790196.md)
- [Hidden treasures from 1930s coins worth real money](https://longbridge.com/en/news/298749843.md)
- [Acquia research shows CMOs, CIOs clash over who leads AI platform decisions](https://longbridge.com/en/news/298919769.md)
- [Trump shrugs off AI existential threat warnings](https://longbridge.com/en/news/298678197.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**